News

TIBSOVO's Continued Success Solidifies Its Position As A Leader In IDH1 Mutant Space Delveinsight
With its ability to specifically inhibit the mutant IDH1 enzyme, TIBSOVO addresses an unmet need in personalized cancer treatment, offering n ...